Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development
- PMID: 15204926
- PMCID: PMC7095027
- DOI: 10.1080/13550280490280292
Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development
Abstract
A novel coronavirus has been recently identified as the causative agent of the severe acute respiratory syndrome (SARS) outbreak that has accounted for more than 8000 infected people worldwide. This review will discuss current knowledge on coronavirus replication, pathogenesis, evolution, and vaccine strategies, as well as the most recent findings on SARS coronavirus.
Similar articles
-
[SARS, possible zoonosis in the area of conflict of pathogenic coronaviruses of animals].Schweiz Arch Tierheilkd. 2003 Jul;145(7):316-22. doi: 10.1024/0036-7281.145.7.316. Schweiz Arch Tierheilkd. 2003. PMID: 12894604 Review. German.
-
Severe acute respiratory syndrome coronavirus pathogenesis, disease and vaccines: an update.Pediatr Infect Dis J. 2004 Nov;23(11 Suppl):S207-14. doi: 10.1097/01.inf.0000144666.95284.05. Pediatr Infect Dis J. 2004. PMID: 15577575 Review.
-
Successful vaccination strategies that protect aged mice from lethal challenge from influenza virus and heterologous severe acute respiratory syndrome coronavirus.J Virol. 2011 Jan;85(1):217-30. doi: 10.1128/JVI.01805-10. Epub 2010 Oct 27. J Virol. 2011. PMID: 20980507 Free PMC article.
-
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus.Microbiol Mol Biol Rev. 2005 Dec;69(4):635-64. doi: 10.1128/MMBR.69.4.635-664.2005. Microbiol Mol Biol Rev. 2005. PMID: 16339739 Free PMC article. Review.
-
Treatment and vaccines for severe acute respiratory syndrome.Lancet Infect Dis. 2005 Mar;5(3):147-55. doi: 10.1016/S1473-3099(05)01307-1. Lancet Infect Dis. 2005. PMID: 15766649 Free PMC article. Review.
Cited by
-
Infectious bronchitis virus 3a protein localizes to a novel domain of the smooth endoplasmic reticulum.J Virol. 2005 May;79(10):6142-51. doi: 10.1128/JVI.79.10.6142-6151.2005. J Virol. 2005. PMID: 15857999 Free PMC article.
-
Differential localization and turnover of infectious bronchitis virus 3b protein in mammalian versus avian cells.Virology. 2006 Feb 20;345(2):337-45. doi: 10.1016/j.virol.2005.09.069. Epub 2005 Nov 18. Virology. 2006. PMID: 16298409 Free PMC article.
-
Crystallization and preliminary X-ray diffraction analysis of the N-terminal domain of human coronavirus OC43 nucleocapsid protein.Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010 Jul 1;66(Pt 7):815-8. doi: 10.1107/S1744309110017616. Epub 2010 Jun 24. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2010. PMID: 20606281 Free PMC article.
-
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs.Pathogens. 2020 Apr 26;9(5):320. doi: 10.3390/pathogens9050320. Pathogens. 2020. PMID: 32357471 Free PMC article.
-
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial.Vaccine. 2008 Nov 25;26(50):6338-43. doi: 10.1016/j.vaccine.2008.09.026. Epub 2008 Sep 26. Vaccine. 2008. PMID: 18824060 Free PMC article. Clinical Trial.
References
-
- Anton IM, Sune C, Meloen RH, Borras-Cuesta F, Enjuanes L. A transmissible gastroenteritis coronavirus nucleoprotein epitope elicits T helper cells that collaborate in the in vitro antibody synthesis to the three major structural viral proteins. Virology. 1995;212:746–751. doi: 10.1006/viro.1995.1535. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous